ZNF394
gene geneOn this page
Also known as ZKSCAN14FLJ12298ZSCAN46
Summary
ZNF394 (zinc finger protein 394, HGNC:18832) is a protein-coding gene on chromosome 7q22.1, encoding Zinc finger protein 394 (Q53GI3). May be involved in transcriptional regulation.
The protein encoded by this gene is a zinc finger protein that inhibits the transcription of mitogen-activated protein kinase signaling pathways. The encoded protein may be involved in cardiac function.
Source: NCBI Gene 84124 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 116 total
- MANE Select transcript:
NM_032164
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18832 |
| Approved symbol | ZNF394 |
| Name | zinc finger protein 394 |
| Location | 7q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZKSCAN14, FLJ12298, ZSCAN46 |
| Ensembl gene | ENSG00000160908 |
| Ensembl biotype | protein_coding |
| OMIM | 619300 |
| Entrez | 84124 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 7 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron
ENST00000337673, ENST00000394177, ENST00000426306, ENST00000462024, ENST00000464401, ENST00000481881, ENST00000485576, ENST00000651061, ENST00000651364, ENST00000926066, ENST00000970609, ENST00000970610, ENST00000970611
RefSeq mRNA: 2 — MANE Select: NM_032164
NM_001345967, NM_032164
CCDS: CCDS5666, CCDS87524
Canonical transcript exons
ENST00000337673 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001797465 | 99493240 | 99494631 |
| ENSE00003569812 | 99498716 | 99498842 |
| ENSE00003660774 | 99499638 | 99500281 |
Expression profiles
Bgee: expression breadth ubiquitous, 266 present calls, max score 92.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.9570 / max 193.0262, expressed in 1775 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 85108 | 11.9570 | 1775 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mononuclear cell | CL:0000842 | 92.44 | gold quality |
| monocyte | CL:0000576 | 92.42 | gold quality |
| blood | UBERON:0000178 | 92.36 | gold quality |
| leukocyte | CL:0000738 | 92.22 | gold quality |
| bone marrow | UBERON:0002371 | 91.93 | gold quality |
| granulocyte | CL:0000094 | 91.57 | gold quality |
| bone marrow cell | CL:0002092 | 91.51 | gold quality |
| calcaneal tendon | UBERON:0003701 | 90.94 | gold quality |
| diaphragm | UBERON:0001103 | 89.58 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.25 | gold quality |
| sural nerve | UBERON:0015488 | 87.92 | gold quality |
| tendon | UBERON:0000043 | 87.58 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 87.58 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.93 | gold quality |
| spleen | UBERON:0002106 | 86.31 | gold quality |
| parotid gland | UBERON:0001831 | 85.84 | gold quality |
| blood vessel layer | UBERON:0004797 | 85.13 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.11 | gold quality |
| skin of abdomen | UBERON:0001416 | 84.98 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 84.85 | gold quality |
| left uterine tube | UBERON:0001303 | 84.76 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.74 | gold quality |
| lymph node | UBERON:0000029 | 84.73 | gold quality |
| tonsil | UBERON:0002372 | 84.71 | gold quality |
| mucosa of stomach | UBERON:0001199 | 84.65 | gold quality |
| left ovary | UBERON:0002119 | 84.41 | gold quality |
| amniotic fluid | UBERON:0000173 | 84.40 | gold quality |
| small intestine | UBERON:0002108 | 84.37 | gold quality |
| popliteal artery | UBERON:0002250 | 84.24 | gold quality |
| tibial artery | UBERON:0007610 | 84.24 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.06 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting ZNF394, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-4763-5P | 98.75 | 63.89 | 854 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-27A-5P | 97.01 | 65.63 | 528 |
| HSA-MIR-4695-3P | 96.71 | 67.21 | 836 |
Literature-anchored findings (GeneRIF, showing 1)
- Overexpression of ZNF394 in the cell inhibits the transcriptional activities of c-Jun and AP-1 reporters. (PMID:15249231)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zkscan14 | ENSMUSG00000029627 |
| rattus_norvegicus | Atp5mf | ENSRNOG00000027049 |
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger protein 394 — Q53GI3 (reviewed: Q53GI3)
Alternative names: Zinc finger protein with KRAB and SCAN domains 14
All UniProt accessions (1): Q53GI3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q53GI3-1 | 1 | yes |
| Q53GI3-3 | 2 |
RefSeq proteins (2): NP_001332896, NP_115540* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF02023
UniProt features (28 total): zinc finger region 7, cross-link 6, region of interest 3, sequence conflict 3, domain 2, compositionally biased region 2, splice variant 2, chain 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q53GI3-F1 | 62.01 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (7): 12, 40, 203, 228, 254, 282, 443
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 149 (showing top):
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, TSENG_IRS1_TARGETS_DN, GNF2_DDX5, GNF2_PTPRC, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, SCGGAAGY_ELK1_02, GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MTOR_UP.N4.V1_DN, PDGF_UP.V1_UP, HOXA9_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
600 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF394 | ARHGAP11B | Q3KRB8 | 461 |
| ZNF394 | CMC2 | Q9NRP2 | 452 |
| ZNF394 | A0A087WTG0 | A0A087WTG0 | 447 |
| ZNF394 | NBPF26 | B4DH59 | 447 |
| ZNF394 | ARHGAP11A | Q6P4F7 | 445 |
| ZNF394 | DUSP22 | Q9NRW4 | 437 |
| ZNF394 | USP19 | O94966 | 418 |
| ZNF394 | TCAF1 | Q9Y4C2 | 407 |
| ZNF394 | PTPN20 | Q4JDL3 | 404 |
| ZNF394 | JHY | Q6NUN7 | 403 |
| ZNF394 | SCML1 | Q9UN30 | 402 |
| ZNF394 | GABPA | Q06546 | 398 |
| ZNF394 | BEND2 | Q8NDZ0 | 398 |
| ZNF394 | ANKRD65 | E5RJM6 | 397 |
| ZNF394 | NEK4 | P51957 | 371 |
| ZNF394 | C1orf53 | Q5VUE5 | 371 |
IntAct
35 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF394 | SCAND1 | psi-mi:“MI:0914”(association) | 0.740 |
| SCAND1 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.740 |
| ZNF394 | CLK2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNDBP1 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CLK2 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF394 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF394 | ZBTB47 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNPS1 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF394 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZSCAN32 | ZNF197 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF397 | ZNF197 | psi-mi:“MI:0914”(association) | 0.530 |
| ZSCAN20 | ZNF197 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ZBTB47 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SCAND1 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF394 | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RNPS1 | ZNF394 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF394 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (21): ZNF394 (Two-hybrid), ZNF394 (Two-hybrid), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), CTNNBL1 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), SCAND1 (Affinity Capture-MS), ZNF394 (Affinity Capture-MS), ZNF394 (Two-hybrid), ZNF394 (Two-hybrid), SCAND1 (Two-hybrid)
ESM2 similar proteins: A1YEP8, A1YEV9, A1YFW2, A1YG26, A1YG48, A1YG60, A2T6E3, A2T6V8, A2T712, A2T736, A2T7D2, A2T7F4, A2T7L7, A2T812, A6QNZ0, O14709, O15535, O43296, O43309, P10073, P17023, P17097, P49910, Q07231, Q12901, Q15776, Q16670, Q1LZ87, Q3MJ62, Q53GI3, Q571J5, Q5JNZ3, Q5RAE6, Q5RBX0, Q5RCD9, Q5RJ54, Q7Z7L9, Q86W11, Q8IZ26, Q8NF99
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
116 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 111 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1089 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:99476401:A:AG | acceptor_gain | 1.0000 |
| 7:99476402:G:GG | acceptor_gain | 1.0000 |
| 7:99479771:G:GT | donor_gain | 1.0000 |
| 7:99479772:A:T | donor_gain | 1.0000 |
| 7:99494629:AACC:A | acceptor_loss | 1.0000 |
| 7:99494630:ACCT:A | acceptor_loss | 1.0000 |
| 7:99494632:C:A | acceptor_loss | 1.0000 |
| 7:99494633:T:G | acceptor_loss | 1.0000 |
| 7:99498714:A:AC | donor_gain | 1.0000 |
| 7:99498715:C:CC | donor_gain | 1.0000 |
| 7:99498715:CT:C | donor_gain | 1.0000 |
| 7:99498715:CTCGG:C | donor_gain | 1.0000 |
| 7:99498838:ATCCC:A | acceptor_gain | 1.0000 |
| 7:99498839:TCCC:T | acceptor_gain | 1.0000 |
| 7:99498840:CCC:C | acceptor_gain | 1.0000 |
| 7:99498840:CCCC:C | acceptor_gain | 1.0000 |
| 7:99498841:CC:C | acceptor_gain | 1.0000 |
| 7:99498841:CCC:C | acceptor_gain | 1.0000 |
| 7:99498841:CCCT:C | acceptor_loss | 1.0000 |
| 7:99498842:CC:C | acceptor_gain | 1.0000 |
| 7:99498842:CCTGG:C | acceptor_loss | 1.0000 |
| 7:99498843:C:CC | acceptor_gain | 1.0000 |
| 7:99498843:CTGGA:C | acceptor_loss | 1.0000 |
| 7:99498844:T:C | acceptor_loss | 1.0000 |
| 7:99499634:TCAC:T | donor_loss | 1.0000 |
| 7:99499636:A:AC | donor_gain | 1.0000 |
| 7:99499637:C:CC | donor_gain | 1.0000 |
| 7:99499637:C:CG | donor_loss | 1.0000 |
| 7:99504731:GAG:G | donor_gain | 1.0000 |
| 7:99476398:TCCA:T | acceptor_loss | 0.9900 |
AlphaMissense
3724 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:99493613:A:C | F534L | 0.998 |
| 7:99493613:A:T | F534L | 0.998 |
| 7:99493615:A:G | F534L | 0.998 |
| 7:99493697:G:C | F506L | 0.998 |
| 7:99493697:G:T | F506L | 0.998 |
| 7:99493699:A:G | F506L | 0.998 |
| 7:99493946:G:C | F423L | 0.998 |
| 7:99493946:G:T | F423L | 0.998 |
| 7:99493948:A:G | F423L | 0.998 |
| 7:99494030:G:C | F395L | 0.998 |
| 7:99494030:G:T | F395L | 0.998 |
| 7:99494032:A:G | F395L | 0.998 |
| 7:99493781:G:C | F478L | 0.997 |
| 7:99493781:G:T | F478L | 0.997 |
| 7:99493783:A:G | F478L | 0.997 |
| 7:99493670:G:C | H515Q | 0.996 |
| 7:99493670:G:T | H515Q | 0.996 |
| 7:99493764:A:G | L484P | 0.996 |
| 7:99493929:A:G | L429P | 0.996 |
| 7:99494114:G:C | F367L | 0.996 |
| 7:99494114:G:T | F367L | 0.996 |
| 7:99494116:A:G | F367L | 0.996 |
| 7:99493658:G:C | H519Q | 0.995 |
| 7:99493658:G:T | H519Q | 0.995 |
| 7:99493668:T:G | Q516P | 0.995 |
| 7:99493672:G:C | H515D | 0.995 |
| 7:99493680:A:G | L512P | 0.995 |
| 7:99493698:A:G | F506S | 0.995 |
| 7:99494003:G:C | H404Q | 0.995 |
| 7:99494003:G:T | H404Q | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000067207 (7:99496379 C>T), RS1000078532 (7:99489575 T>C), RS1000243877 (7:99502019 T>C,G), RS1000298523 (7:99495733 G>A), RS1000415466 (7:99496072 T>C), RS1000799410 (7:99491247 A>G), RS1000911617 (7:99489931 G>T), RS1001030208 (7:99497684 T>C), RS1001083502 (7:99490994 T>C), RS1001376030 (7:99494606 T>A,C), RS1001428344 (7:99494785 A>G), RS1001497581 (7:99495887 G>T), RS1001801298 (7:99492922 C>T), RS1001990582 (7:99499316 C>T), RS1002057189 (7:99500314 G>A,C)
Disease associations
OMIM: gene MIM:619300 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004730_2 | Facial emotion recognition (sad faces) | 3.000000e-06 |
| GCST008667_7 | Smoking status (heavy vs never) | 8.000000e-08 |
| GCST90000047_140 | Age at first sexual intercourse | 2.000000e-15 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008329 | facial emotion recognition measurement |
| EFO:0006527 | smoking status measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
42 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Doxorubicin | decreases expression, decreases response to substance | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| geraniol | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| abrine | increases expression | 1 |
| elesclomol | increases expression, decreases reaction | 1 |
| (4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II) | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Acetylcysteine | decreases reaction, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW40 | HEK293 eGFP-ZNF394 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.